Shilajit and Warfarin

Supplement–drug interaction evidence from the TruthStack database.

SeverityHIGH
Evidence TierModerate
Interaction TypeBLEEDING RISK
MechanismPHARMACODYNAMIC
Last Reviewed2026-02-16

Summary

Shilajit may have antiplatelet properties. Combined with warfarin, literature flags potential increased bleeding risk. Discuss with your prescriber or pharmacist.

Higher-Concern Contexts

This interaction may be of particular concern in the following contexts:

CYP Enzyme Profiles

Published CYP enzyme data for compounds in this interaction:

Warfarin: CYP1A2 substrate (weak), CYP2C9 substrate (strong), CYP3A4 substrate (moderate)

API Reference

GET https://api.truthstack.co/v1/check?c1=Shilajit&c2=Warfarin

Open, unauthenticated. Returns JSON. Developer documentation

Related Interactions

Cbd + Warfarin Goldenseal + Warfarin Vitamin K + Warfarin Vitamin K2 + Warfarin Berberine + Warfarin Biotin + Warfarin Calcium + Warfarin CoQ10 + Warfarin
What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.